Scil Proteins took up the process development and early stage GMP manufacturing for a recombinant protein candidate.
Scil Proteins CEO Ulrike Fiedler said the company is happy that Lundbeck selected their protein manufacturing competence and facilities to deliver their protein.
Scil Proteins manufactures Boehringer Mannheim and Roche developed protein Reteplase for the treatment of myocardial infarction.